How would I detect dimerisation in a cagrilintide vial without sending it to PeptideMeter?

The specifics, since they change the answer: dimerisation · cagrilintide · PeptideMeter.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What is the correct sequence, and where is the step that people usually skip?

The honest answer is that most defects found are cosmetic and the few that are not are obvious once you know the list.

Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.

Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.

Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.

Do not open a vial you intend to return or claim on; photograph it sealed first.

Photograph anything unexpected before touching it further.

Photograph anything unexpected before you touch it further; a photograph is the only evidence that survives.

Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.

Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.

Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.

The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.

The lot code has to be on the vial. A code on the box ties nothing to anything.

The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.

After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.

Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.

Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Passing inspection is a weak result. It rules out the obvious and nothing else.

edited 29 Dec 2024 by Dr_Ingrid_Baumgartner — added the method parameters

This is a two-minute procedure that resolves a large fraction of the questions people ask afterwards.

Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.

Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.

A vial that passes inspection has passed a very weak test. It has not been verified.

Inspect before reconstitution. Afterwards you cannot tell whose particle it is.

Answering this needs to know what you are looking for, because most people inspect vials without a list and therefore see nothing.

Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.

The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.

None of the above is a recommendation to administer anything. Research-use-only material is not approved for human use, and the arithmetic being correct does not make the decision safe.

Crimp, stopper, label, contents. Light background and dark background.